Genvor Inc. Files Amended 10-K for Fiscal Year Ended September 30, 2022

TL;DR

<b>Genvor Inc. has filed an amended 10-K for FY2022, detailing financial data and corporate history.</b>

AI Summary

Genvor Inc (GNVR) filed a Amended Annual Report (10-K/A) with the SEC on January 16, 2024. Genvor Inc. filed an amended 10-K report for the fiscal year ended September 30, 2022. The company was formerly known as Allure Worldwide, Inc., with a name change effective October 31, 2019. Genvor Inc. is incorporated in Nevada and operates in the Agriculture Production - Crops sector. The filing includes data related to Series A Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings for various periods. The company received a Paycheck Protection Program loan on April 9, 2020.

Why It Matters

For investors and stakeholders tracking Genvor Inc, this filing contains several important signals. This amended filing provides updated financial information and corporate disclosures for Genvor Inc., which is crucial for investors to assess the company's current financial health and historical performance. The inclusion of specific financial instruments like Series A Preferred Stock and details on stock components offers insight into the company's capital structure and equity evolution.

Risk Assessment

Risk Level: low — Genvor Inc shows low risk based on this filing. The filing is an amendment to a previous 10-K, indicating potential corrections or updates to previously reported information, but the content itself does not reveal immediate high-risk factors.

Analyst Insight

Review the specific changes and additions in this amended 10-K filing to understand any material updates to Genvor Inc.'s financial position or disclosures.

Key Numbers

• 20220930 — Fiscal Year End (Conformed period of report)
• 20240116 — Filing Date (As of date)
• 0001792941 — Central Index Key (Genvor Inc. identifier)
• 000-56589 — SEC File Number (SEC filing number)
• 20191031 — Date of Name Change (From Allure Worldwide, Inc. to Genvor Inc.)
• 0832054746 — IRS Number (Company's IRS number)
• 2020-04-09 — Paycheck Protection Program Loan Date (Date loan was received)

Key Players & Entities

• Genvor Inc. (company) — Filer name
• Allure Worldwide, Inc. (company) — Former company name
• NV (location) — State of incorporation
• Chapel Hill (location) — Business address city
• NC (location) — Business address state
• 0001493152-24-002461 (filing_id) — Accession number
• 20220930 (date) — Fiscal year end
• 20240116 (date) — Filing date

FAQ

Key Dates

• 2022-09-30: Fiscal Year End — Reporting period for the 10-K filing.
• 2024-01-16: Filing Date — Date the amended 10-K was filed with the SEC.
• 2019-10-31: Name Change — Date Genvor Inc. changed its name from Allure Worldwide, Inc.

Glossary

10-K/A

An amended annual report filed with the SEC. (Indicates that the company is providing updated or corrected information for its annual financial disclosure.)

Key Financial Figures

• $246,000 — abilities and net loss by approximately $246,000. Effects of Restatement See Note 1
• $100 billion — and viruses are now estimated to exceed $100 billion. Alarming to the FDA are the fungi "Asp
• $500 million — n in the United States at approximately $500 million through two categories of loss: market
• $2 billion — these three crops alone represent over $2 billion annually based on an average trait fee
• $13 — nually based on an average trait fee of $13 per acre on approximately 170 million a
• $1.2 billion — S. corn crops alone account for roughly $1.2 billion of the estimated $2 billion. Biopesti
• $4.8 billion — alone is currently estimated to be over $4.8 billion annually. Genvor's technology is effe
• $5 — ty securities with a price of less than $5.00, other than securities registered on
• $16,041,937 — e Company had an accumulated deficit of $16,041,937, incurred a net loss of $4,240,109 for
• $4,240,109 — of $16,041,937, incurred a net loss of $4,240,109 for the nine months ended September 30,
• $4,063,881 — Our loss from operations increased to $4,063,881 during the nine months ended September
• $3,101,904 — ber 30, 2022, from an operating loss of $3,101,904 in the year ended December 31, 2021. Th

Filing Documents

• form10-ka.htm (10-K/A) — 1008KB
• ex31-1.htm (EX-31.1) — 17KB
• ex31-2.htm (EX-31.2) — 17KB
• ex32-1.htm (EX-32.1) — 7KB
• ex32-2.htm (EX-32.2) — 7KB
• form10-ka_001.jpg (GRAPHIC) — 2KB
• 0001493152-24-002461.txt (&nbsp;) — 4859KB
• gnvr-20220930.xsd (EX-101.SCH) — 38KB
• gnvr-20220930_cal.xml (EX-101.CAL) — 43KB
• gnvr-20220930_def.xml (EX-101.DEF) — 160KB
• gnvr-20220930_lab.xml (EX-101.LAB) — 296KB
• gnvr-20220930_pre.xml (EX-101.PRE) — 233KB
• form10-ka_htm.xml (XML) — 624KB

Business

Business 3 Item 1A.

Risk Factors

Risk Factors 5 Item 1B. Unresolved Staff Comments 5 Item 2.

Properties

Properties 5 Item 3.

Legal Proceedings

Legal Proceedings 5 Item 4. Mine Safety Disclosures 5 PART II. Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 6 Item 6.

Selected Financial Data

Selected Financial Data 7 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operation

Management's Discussion and Analysis of Financial Condition and Results of Operation 7 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 11 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 12 Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 13 Item 9A.

Controls and Procedures

Controls and Procedures 13 Item 9B. Other Information 14 PART III. Item 10. Directors, Executive Officers and Corporate Governance 15 Item 11.

Executive Compensation

Executive Compensation 19 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 19 Item 13. Certain Relationships and Related Transactions, and Director Independence 21 Item 14. Principal Accounting Fees and Services 21 PART IV. Item 15. Exhibits, Financial Statement Schedules 22

Signatures

Signatures 23 Exhibits 2 Table of Contents FORWARD LOOKING STATEMENTS This Annual Report on Form 10-K contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as "anticipate," "expects," "intends," "plans," "believes," "seeks" and "estimates" and variations of these words and similar expressions are intended to identify forward-looking of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Form 10-K. Investors should carefully consider all of such risks before making an investment decision with respect to the Company's stock. The following discussion and analysis should be read in conjunction with our financial statements for Genvor Incorporated Such discussion represents only the best present assessment from our Management. PART I Item 1: Description of Business Genvor Incorporated (the "Company" or "Genvor") was incorporated in Florida on September 26, 2018, as "Allure Worldwide, Inc.," and as of November 18, 2019, redomiciled to Nevada. On June 24, 2022, the Company changed its name to from "Allure Worldwide, Inc." to "Genvor Incorporated." The Company was originally formed with the intention of seeking to acquire the assets or shares of an entity actively engaged in business which generates revenues, in exchange for its securities.

View Full Filing

View this 10-K/A filing on SEC EDGAR